Oral Anticoagulation and Risk of Adverse Clinical Outcomes in Venous Thromboembolism.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2025.1109
Abstract: Importance Over the past decade, there has been a considerable shift in the use of pharmacologic agents for venous thromboembolism (VTE), with direct oral anticoagulants replacing warfarin as the drugs of choice for VTE recurrence… read more here.
Keywords: vte; venous thromboembolism; risk; rivaroxaban warfarin ... See more keywords
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.2338
Abstract: Key Points Question What is the risk of venous thromboembolism (VTE) among outpatients with COVID-19? Findings In this cohort study of 398 530 adult outpatients with COVID-19, the rate of VTE was low in the first… read more here.
Keywords: venous thromboembolism; vte; risk; risk venous ... See more keywords
Association of Anti–Factor Xa–Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2017.3787
Abstract: Importance The efficacy of anti–factor Xa (anti-Xa)–guided dosing of thromboprophylaxis after trauma remains controversial. Objective To assess whether dosing of enoxaparin sodium based on peak anti-Xa levels is associated with the venous thromboembolism (VTE) rate… read more here.
Keywords: vte; group; trauma; guided dosing ... See more keywords
Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2018.2081
Abstract: Importance The guidelines by the National Comprehensive Cancer Network and the American Society for Clinical Oncology recommend the routine use of thromboprophylaxis for patients with gastric adenocarcinoma. However, many physicians in Asian countries use venous… read more here.
Keywords: incidence; vte; use; gastric adenocarcinoma ... See more keywords
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma ‐ specific venous thrombosis prediction models
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25837
Abstract: Venous thromboembolic events (VTE) are a frequent complication of lymphoma. We conducted a retrospective analysis to compare VTE risk in diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL). Subjects were randomly assigned to training… read more here.
Keywords: lymphoma; vte; risk; venous thrombosis ... See more keywords
External validation of the HIGH‐2‐LOW model: A predictive score for venous thromboembolism after allogeneic transplant
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26521
Abstract: In patients undergoing hematopoietic cell transplantation (HCT), venous thromboembolism (VTE) remains a serious complication that lacks validated risk assessment models (RAMs) to guide thromboprophylaxis. To address this dilemma, we performed a temporal and external validation… read more here.
Keywords: high low; vte; external validation; venous thromboembolism ... See more keywords
Venous thromboembolism after COVID‐19 vaccination in patients with thrombophilia
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Hematology"
DOI: 10.1002/ajh.26848
Abstract: Patients with thrombophilia remain concerned about venous thromboembolism (VTE) risk with COVID‐19 vaccinations. The aim of this study was to examine VTE outcomes in patients with inherited or acquired thrombophilia who were vaccinated for COVID‐19.… read more here.
Keywords: vaccination; vaccination patients; venous thromboembolism; vte ... See more keywords
External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center.
Sign Up to like & getrecommendations! Published in 2023 at "American journal of hematology"
DOI: 10.1002/ajh.26928
Abstract: Venous thromboembolism (VTE) is a significant complication for cancer patients undergoing systemic therapy. We performed an independent external validation for a recently derived and validated a novel electronic health record (EHR) VTE risk score in… read more here.
Keywords: vte; risk; cancer center; score ... See more keywords
Guideline Implementation: Prevention of Venous Thromboembolism 1.6 www.aornjournal.org/content/cme
Sign Up to like & getrecommendations! Published in 2018 at "AORN Journal"
DOI: 10.1002/aorn.12146
Abstract: Venous thromboembolism (VTE) is a serious and costly complication of surgery. Many cases of health care-associated VTE could be prevented with the use of evidenced-based interventions. Perioperative nurses are in a position to advocate for… read more here.
Keywords: vte; guideline implementation; prevention venous; venous thromboembolism ... See more keywords
Simple, Effective and Validated. VTE CASE Risk Assessment Score for Venous Thromboembolism in Metastatic Germ Cell Tumour Patients Before First‐Line Chemotherapy
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.70295
Abstract: Venous thromboembolism (VTE) may jeopardise excellent treatment results of germ cell tumours (GCT). We previously constructed a VTE risk score for GCT patients qualified for first‐line chemotherapy (CTH), including vein compression, clinical stage (CS) and… read more here.
Keywords: vte; first line; line chemotherapy; venous thromboembolism ... See more keywords
Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.70568
Abstract: Cancer‐associated thromboembolism has been thoroughly investigated in previous studies, and direct oral anticoagulants (DOACs) were established for the treatment and prevention of venous thromboembolism (VTE). However, the risks of cancer‐associated arterial thromboembolism (ATE) and the… read more here.
Keywords: cancer; vte; thromboembolism patients; thromboembolism ... See more keywords